{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:07:17Z","timestamp":1787897237954,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is associated with an increased risk of <jats:italic>type 2 diabetes mellitus<\/jats:italic> (T2DM) but its association with prediabetes and T2DM is unknown in Qatar. <jats:italic>A cross sectional analysis of 3,017 Qatari subjects from the Qatar Biobank, identified 749 women aged 18\u201340 years, 720 of whom were assessed by the National Institute for Health (NIH) Guidelines for PCOS<\/jats:italic>. Prediabetes (HbA1c 5.7\u20136.4% and\/or impaired fasting glucose (IFG<jats:italic>): fasting plasma glucose (FPG)<\/jats:italic> 100\u2013125\u2009mg\/dL (5.6\u20136.9\u2009mmol\/L)), and T2DM (fasting plasma glucose\u2009&gt;\u2009125\u2009mg\/dL (\u22657\u2009mmol\/L), and\/or HbA1c\u2009\u2265\u20096.5%) were determined. <jats:italic>The prevalence of prediabetes was 10.6% and the prevalence of undiagnosed diabetes was found to be 4.0% in the total population. Overall, 12.1% of 720 women had PCOS, of whom FPG and HbA1c were available in 62 women with PCOS: 19.4% had prediabetes and 9.7% had diabetes. An adverse cardiovascular risk profile for IFG women compared to normal women was found<\/jats:italic>. Women with PCOS alone had a similar adverse cardiovascular profile as those with IFG alone and T2DM. Thus, the risk of prediabetes and diabetes is increased in Qatari women with PCOS, with an adverse cardiovascular risk profile similar to that seen in prediabetes and T2DM.<\/jats:p>","DOI":"10.1038\/s41598-018-21987-6","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T16:34:32Z","timestamp":1519144472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome"],"prefix":"10.1038","volume":"8","author":[{"given":"Soha R.","family":"Dargham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-6654","authenticated-orcid":false,"given":"Abeer El","family":"Shewehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-6831","authenticated-orcid":false,"given":"Youssra","family":"Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-7257","authenticated-orcid":false,"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"21987_CR1","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro, R. S. et al. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism 98, 4565\u20134592, https:\/\/doi.org\/10.1210\/jc.2013-2350 (2013).","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"21987_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E. & Yildiz, B. O. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31, 2841\u20132855, https:\/\/doi.org\/10.1093\/humrep\/dew218 (2016).","journal-title":"Hum Reprod"},{"key":"21987_CR3","doi-asserted-by":"publisher","unstructured":"Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic ovary syndrome. Lancet 370, 685\u2013697, https:\/\/doi.org\/10.1016\/S0140-6736(07)61345-2 (2007).","DOI":"10.1016\/S0140-6736(07)61345-2"},{"key":"21987_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann, D. A. Polycystic ovary syndrome. N Engl J Med 352, 1223\u20131236, https:\/\/doi.org\/10.1056\/NEJMra041536 (2005). 352\/12\/1223.","journal-title":"N Engl J Med"},{"key":"21987_CR5","doi-asserted-by":"publisher","unstructured":"Sathyapalan, T. & Atkin, S. Review Topic On Mechanisms In Endocrinology Recent Advances in the Cardiovascular Aspects of Polycystic Ovary Syndrome. European journal of endocrinology\/European Federation of Endocrine Societies, https:\/\/doi.org\/10.1530\/EJE-11-0755 (2011).","DOI":"10.1530\/EJE-11-0755"},{"key":"21987_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/humupd\/dmp008","volume":"15","author":"L Moran","year":"2009","unstructured":"Moran, L. & Teede, H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 15, 477\u2013488, https:\/\/doi.org\/10.1093\/humupd\/dmp008 (2009).","journal-title":"Hum Reprod Update"},{"key":"21987_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March, W. A. et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25, 544\u2013551, https:\/\/doi.org\/10.1093\/humrep\/dep399 (2010).","journal-title":"Hum Reprod"},{"key":"21987_CR8","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jc.2012-1690","volume":"97","author":"CL Morgan","year":"2012","unstructured":"Morgan, C. L., Jenkins-Jones, S., Currie, C. J. & Rees, D. A. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab 97, 3251\u20133260, https:\/\/doi.org\/10.1210\/jc.2012-1690 (2012).","journal-title":"J Clin Endocrinol Metab"},{"key":"21987_CR9","doi-asserted-by":"publisher","first-page":"E447","DOI":"10.1210\/jc.2013-2007","volume":"99","author":"AE Joham","year":"2014","unstructured":"Joham, A. E., Ranasinha, S., Zoungas, S., Moran, L. & Teede, H. J. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 99, E447\u2013452, https:\/\/doi.org\/10.1210\/jc.2013-2007 (2014).","journal-title":"J Clin Endocrinol Metab"},{"key":"21987_CR10","doi-asserted-by":"publisher","unstructured":"Pelanis, R. et al. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS. Human Reproduction, 1\u20138, https:\/\/doi.org\/10.1093\/humrep\/dex294 (2017).","DOI":"10.1093\/humrep\/dex294"},{"key":"21987_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/humrep\/dew329","volume":"32","author":"ME Ollila","year":"2017","unstructured":"Ollila, M. E. et al. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod 32, 423\u2013431, https:\/\/doi.org\/10.1093\/humrep\/dew329 (2017).","journal-title":"Hum Reprod"},{"key":"21987_CR12","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tabak","year":"2012","unstructured":"Tabak, A. G., Herder, C., Rathmann, W., Brunner, E. J. & Kivimaki, M. Prediabetes: a high-risk state for diabetes development. Lancet 379, 2279\u20132290, https:\/\/doi.org\/10.1016\/s0140-6736(12)60283-9 (2012).","journal-title":"Lancet"},{"key":"21987_CR13","doi-asserted-by":"publisher","first-page":"e0181467","DOI":"10.1371\/journal.pone.0181467","volume":"12","author":"SR Dargham","year":"2017","unstructured":"Dargham, S. R., Ahmed, L., Kilpatrick, E. S. & Atkin, S. L. The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population. PLoS One 12, e0181467, https:\/\/doi.org\/10.1371\/journal.pone.0181467 (2017).","journal-title":"PLoS One"},{"key":"21987_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJWH.S120027","volume":"9","author":"E Sharif","year":"2017","unstructured":"Sharif, E., Rahman, S., Zia, Y. & Rizk, N. M. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health 9, 1\u201310, https:\/\/doi.org\/10.2147\/ijwh.s120027 (2017).","journal-title":"Int J Womens Health"},{"key":"21987_CR15","unstructured":"World, Health & Organization. Waist circumference and waist\u2013hip ratio Report of a WHO expert consultation, Geneva (2008)."},{"key":"21987_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr","year":"2008","unstructured":"D\u2019Agostino, R. B. Sr. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743\u2013753, https:\/\/doi.org\/10.1161\/circulationaha.107.699579 (2008).","journal-title":"Circulation"},{"key":"21987_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/toxsci\/kfr268","volume":"125","author":"SZ Xu","year":"2012","unstructured":"Xu, S. Z. et al. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure. Toxicological sciences: an official journal of the Society of Toxicology 125, 56\u201368, https:\/\/doi.org\/10.1093\/toxsci\/kfr268 (2012).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"21987_CR18","doi-asserted-by":"publisher","unstructured":"Celik, C., Tasdemir, N., Abali, R., Bastu, E. & Yilmaz, M. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertil Steril 101, 1123-1128.e1121, https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.050 (2014).","DOI":"10.1016\/j.fertnstert.2013.12.050"},{"key":"21987_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2796.2004.01336.x","volume":"256","author":"S Soderberg","year":"2004","unstructured":"Soderberg, S. et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med 256, 37\u201347, https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01336.x (2004).","journal-title":"J Intern Med"},{"key":"21987_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","volume":"24","author":"NG Forouhi","year":"2007","unstructured":"Forouhi, N. G., Luan, J., Hennings, S. & Wareham, N. J. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990\u20132000. Diabet Med 24, 200\u2013207, https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02068.x (2007).","journal-title":"Diabet Med"},{"key":"21987_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2337\/dc07-9920","volume":"30","author":"DM Nathan","year":"2007","unstructured":"Nathan, D. M. et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753\u2013759, https:\/\/doi.org\/10.2337\/dc07-9920 (2007).","journal-title":"Diabetes Care"},{"key":"21987_CR22","doi-asserted-by":"publisher","first-page":"e1002095","DOI":"10.1371\/journal.pmed.1002095","volume":"13","author":"U Mudaliar","year":"2016","unstructured":"Mudaliar, U. et al. Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis. PLoS Med 13, e1002095, https:\/\/doi.org\/10.1371\/journal.pmed.1002095 (2016).","journal-title":"PLoS Med"},{"key":"21987_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0021-9150(02)00280-0","volume":"165","author":"S van Wissen","year":"2002","unstructured":"van Wissen, S. et al. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis 165, 361\u2013366 (2002).","journal-title":"Atherosclerosis"},{"key":"21987_CR24","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1097\/HJH.0000000000000739","volume":"33","author":"JK Vishram","year":"2015","unstructured":"Vishram, J. K. et al. Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy. J Hypertens 33, 2422\u20132430, https:\/\/doi.org\/10.1097\/HJH.0000000000000739 (2015).","journal-title":"J Hypertens"},{"key":"21987_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/HJH.0000000000001192","volume":"35","author":"H Boardman","year":"2017","unstructured":"Boardman, H. et al. Aortic stiffness and blood pressure variability in young people: a multimodality investigation of central and peripheral vasculature. J Hypertens 35, 513\u2013522, https:\/\/doi.org\/10.1097\/hjh.0000000000001192 (2017).","journal-title":"J Hypertens"},{"key":"21987_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","volume":"110","author":"S Malik","year":"2004","unstructured":"Malik, S. et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245\u20131250, https:\/\/doi.org\/10.1161\/01.cir.0000140677.20606.0e (2004).","journal-title":"Circulation"},{"key":"21987_CR27","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild, R. A. et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 95, 2038\u20132049, https:\/\/doi.org\/10.1210\/jc.2009-2724 (2010).","journal-title":"J Clin Endocrinol Metab"},{"key":"21987_CR28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman, N. F. et al. American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2. Endocr Pract 21, 1415\u20131426, https:\/\/doi.org\/10.4158\/ep15748.dscpt2 (2015).","journal-title":"Endocr Pract"},{"key":"21987_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1210\/jc.2015-3780","volume":"101","author":"A Dunaif","year":"2016","unstructured":"Dunaif, A. Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab 101, 759\u2013768, https:\/\/doi.org\/10.1210\/jc.2015-3780 (2016).","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21987-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:48:23Z","timestamp":1671590903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21987"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21987-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3619"}}